Korean J Pancreas Biliary Tract.  2016 Jan;21(1):19-23. 10.15279/kpba.2016.21.1.19.

The Prevention of Pancreatitis after Endoscopic Papillectomy; Stent versus No Stent

Affiliations
  • 1Department of Internal Medicine, Kyungpook National University College of Medicine, Daegu, Korea. cmcho@knu.ac.kr

Abstract

Endoscopic papillectomy (EP) has been considered to be a less invasive, alternative therapy to surgery for ampullary adenoma. However, complication rates after EP could not be ignored, when compared to endoscopic resection for gastrointestinal lesions. Among them, the prevalence of postpapillectomy pancreatitis is higher in EP than ERCP. The prophylactic placement of a pancreatic stent has been reported to decrease the risk of pancreatitis after EP. However, since pancreatic stent placement after EP is not always successful, various novel techniques have been developed to ensure reliable stent placement. Despite the recent advances in EP, a prospective, randomized, controlled study with a larger number of patients is needed to assess the efficacy of pancreatic stent placement to prevent pancreatitis.

Keyword

Endoscopic papillectomy; Ampullary adenoma; Pancreatitis; Pancreatic stent

MeSH Terms

Adenoma
Cholangiopancreatography, Endoscopic Retrograde
Humans
Pancreatitis*
Prevalence
Prospective Studies
Stents*
Full Text Links
  • KJPBT
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2022 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr